SCHEMBL292307

SCHEMBL292307

O=c1[nH]sc2cccc(OC(F)F)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ DDAH1 O94760 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ CACNA1B Q00975 1/20 0.41
▸ APBA1 Q02410 1/20 0.41
▸ POLB P06746 3/20 0.40
▸ MAOA P21397 1/20 0.36
▸ PDE4A P27815 2/20 0.33
▸ PDE4B Q07343 2/20 0.33
▸ PDE4C Q08493 2/20 0.33
▸ PDE4D Q08499 2/20 0.33
▸ PDE3B Q13370 2/20 0.33
▸ PDE3A Q14432 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10843641 0.78 MAOA (0.54) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL1710671 0.75 ALDH1A1 (0.48) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL292306 0.74 ALDH1A1 (0.41) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL8596062 0.68 ALDH1A1 (0.48) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL2970289 0.68 MAPT (0.48) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL11213296 0.68 ALDH1A1 (0.48) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL725796 0.68 ALDH1A1 (0.48) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL9827851 0.68 LMNA (0.56) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL10587136 0.66 MAPT (0.46) LMNAALDH1A1MAPTKDM4EHTT
SCHEMBL31313035 0.65 ATM (0.35) ALDH1A1MAPTKDM4EPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064196-B1 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2012-03-14 — — EP disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 — — US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 — — US disclosed
EP-2064196-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF Aktiengesellschaft (DE) 2009-06-03 — — EP disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 LMNA 4034/4885ALDH1A1 452/4885MAPT 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback